These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17259471)

  • 21. Simultaneous islet and kidney transplantation in seven patients with type 1 diabetes and end-stage renal disease using a glucocorticoid-free immunosuppressive regimen with alemtuzumab induction.
    Tan J; Yang S; Cai J; Guo J; Huang L; Wu Z; Chen J; Liao L
    Diabetes; 2008 Oct; 57(10):2666-71. PubMed ID: 18633105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade.
    Posselt AM; Szot GL; Frassetto LA; Masharani U; Tavakol M; Amin R; McElroy J; Ramos MD; Kerlan RK; Fong L; Vincenti F; Bluestone JA; Stock PG
    Transplantation; 2010 Dec; 90(12):1595-601. PubMed ID: 20978464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and cardiovascular safety of daclizumab, mycophenolate mofetil, tacrolimus, and early steroid withdrawal in renal transplant recipients: a multicenter, prospective, pilot trial.
    Abramowicz D; Vanrenterghem Y; Squifflet JP; Kuypers D; Mourad M; Meurisse M; Wissing M
    Clin Transplant; 2005 Aug; 19(4):475-82. PubMed ID: 16008591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Islet transplantation is associated with an improvement of cardiovascular function in type 1 diabetic kidney transplant patients.
    Fiorina P; Gremizzi C; Maffi P; Caldara R; Tavano D; Monti L; Socci C; Folli F; Fazio F; Astorri E; Del Maschio A; Secchi A
    Diabetes Care; 2005 Jun; 28(6):1358-65. PubMed ID: 15920052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Islet transplantation for brittle type 1 diabetes: the UIC protocol.
    Gangemi A; Salehi P; Hatipoglu B; Martellotto J; Barbaro B; Kuechle JB; Qi M; Wang Y; Pallan P; Owens C; Bui J; West D; Kaplan B; Benedetti E; Oberholzer J
    Am J Transplant; 2008 Jun; 8(6):1250-61. PubMed ID: 18444920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of low dose tacrolimus, mycophenolate mofetil and maintenance IL-2 receptor blockade in an islet transplant recipient.
    Kaplan B; West P; Neeley H; Martellotto J; Iqbal R; Gangemi A; Hatipoglu B; Benedetti E; Oberholzer J
    Clin Transplant; 2008; 22(2):250-3. PubMed ID: 18339148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [End-stage nephropathy in type 1-diabetes mellitus - kidney transplantation alone or combined with islet or pancreas transplantation?].
    Lehman R; Gerber PA
    Ther Umsch; 2011 Dec; 68(12):699-706. PubMed ID: 22139985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary graft function, metabolic control, and graft survival after islet transplantation.
    Vantyghem MC; Kerr-Conte J; Arnalsteen L; Sergent G; Defrance F; Gmyr V; Declerck N; Raverdy V; Vandewalle B; Pigny P; Noel C; Pattou F
    Diabetes Care; 2009 Aug; 32(8):1473-8. PubMed ID: 19638525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement in β-cell secretory capacity after human islet transplantation according to the CIT07 protocol.
    Rickels MR; Liu C; Shlansky-Goldberg RD; Soleimanpour SA; Vivek K; Kamoun M; Min Z; Markmann E; Palangian M; Dalton-Bakes C; Fuller C; Chiou AJ; Barker CF; Luning Prak ET; Naji A
    Diabetes; 2013 Aug; 62(8):2890-7. PubMed ID: 23630300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunosuppression and procedure-related complications in 26 patients with type 1 diabetes mellitus receiving allogeneic islet cell transplantation.
    Hafiz MM; Faradji RN; Froud T; Pileggi A; Baidal DA; Cure P; Ponte G; Poggioli R; Cornejo A; Messinger S; Ricordi C; Alejandro R
    Transplantation; 2005 Dec; 80(12):1718-28. PubMed ID: 16378067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement in insulin sensitivity after human islet transplantation for type 1 diabetes.
    Rickels MR; Kong SM; Fuller C; Dalton-Bakes C; Ferguson JF; Reilly MP; Teff KL; Naji A
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1780-5. PubMed ID: 24085506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraportal islet allografts in type I diabetes mellitus.
    Alejandro R; Burke G; Shapiro ET; Strasser S; Nery J; Ricordi C; Esquenazi V; Miller J; Mintz DH
    Transplant Proc; 1992 Jun; 24(3):959-60. PubMed ID: 1604685
    [No Abstract]   [Full Text] [Related]  

  • 33. Human islet allotransplantation with Basiliximab in type I diabetic patients with end-stage renal failure.
    Oberholzer J; Toso C; Triponez F; Ris F; Bucher P; Demirag A; Lou J; Majno P; Buehler L; Philippe J; Morel P
    Transplant Proc; 2002 May; 34(3):823-5. PubMed ID: 12034197
    [No Abstract]   [Full Text] [Related]  

  • 34. Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab.
    Posselt AM; Bellin MD; Tavakol M; Szot GL; Frassetto LA; Masharani U; Kerlan RK; Fong L; Vincenti FG; Hering BJ; Bluestone JA; Stock PG
    Am J Transplant; 2010 Aug; 10(8):1870-80. PubMed ID: 20659093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial.
    Lablanche S; Vantyghem MC; Kessler L; Wojtusciszyn A; Borot S; Thivolet C; Girerd S; Bosco D; Bosson JL; Colin C; Tetaz R; Logerot S; Kerr-Conte J; Renard E; Penfornis A; Morelon E; Buron F; Skaare K; Grguric G; Camillo-Brault C; Egelhofer H; Benomar K; Badet L; Berney T; Pattou F; Benhamou PY;
    Lancet Diabetes Endocrinol; 2018 Jul; 6(7):527-537. PubMed ID: 29776895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-Term Follow-Up of the Edmonton Protocol of Islet Transplantation in the United States.
    Brennan DC; Kopetskie HA; Sayre PH; Alejandro R; Cagliero E; Shapiro AM; Goldstein JS; DesMarais MR; Booher S; Bianchine PJ
    Am J Transplant; 2016 Feb; 16(2):509-17. PubMed ID: 26433206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Islet of Langerhans transplantation for the treatment of type 1 diabetes.
    Bucher P; Mathe Z; Bosco D; Andres A; Bühler LH; Morel P; Berney T
    Swiss Surg; 2003; 9(5):242-6. PubMed ID: 14601328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term (> 30 months) follow-up of a single successful kidney-islet transplant recipient.
    Brennan DC; Flavin KS; Scharp DW; Lacy PE; Olack BJ; Swanson C; Mohanakumar T; White NH
    Transplant Proc; 1997 Jun; 29(4):2231-3. PubMed ID: 9193605
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol.
    Ryan EA; Lakey JR; Rajotte RV; Korbutt GS; Kin T; Imes S; Rabinovitch A; Elliott JF; Bigam D; Kneteman NM; Warnock GL; Larsen I; Shapiro AM
    Diabetes; 2001 Apr; 50(4):710-9. PubMed ID: 11289033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequential kidney/islet transplantation using prednisone-free immunosuppression.
    Kaufman DB; Baker MS; Chen X; Leventhal JR; Stuart FP
    Am J Transplant; 2002 Aug; 2(7):674-7. PubMed ID: 12201371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.